Detailed Program
- Current Page
- Program > Detailed Program
English Session
Korean SessionOral Presentation & HF Research Award
| Day 2 - Fri, Sep 12 | ||||
|---|---|---|---|---|
| Room C | ||||
| 09:00-10:20 | ENG Oral Presentation & HF Research Award |
Jin-Ok Jeong (Chungnam National Univ., Korea)
, Kye Hun Kim (Chonnam National Univ., Korea) |
||
| Judges: Min Gyu Kong (Soon Chun Hyang Univ., Korea), Bong-Joon Kim (Kosin Univ., Korea), Jong-Ho Nam (Yeungnam Univ., Korea), Ju-Hee Lee (Chungbuk National Univ., Korea) | ||||
| 09:00-09:10 | Deep Learning-based Modeling of Gender-Affirming Hormone Therapy and Circulating miRNA Signatures to Predict Heart Failure Risk in Transgender Individuals | Rifaldy Fajar (IMCDS-BRF, Indonesia) | ||
| 09:10-09:20 | Clinical Implications of Significant Tricuspid Regurgitation in LVAD Recipients: Prognostic Relevance and Postoperative Trajectory | Heayoung Shin (Sungkyunkwan Univ., Korea) | ||
| 09:20-09:30 | Immunopathologic Features of Biopsy-Confirmed Myocarditis after COVID-19 mRNA Vaccination | Eui-Soon Kim (The Catholic Univ., Korea) | ||
| 09:30-09:40 | Comparative Prognostic Value of Frailty Assessment Tools in Older Patients with Heart Failure: A Post-hoc Analysis of FRAGILE-HF | Yoshiaki Ikeda (Juntendo Univ., Japan) | ||
| 09:40-09:50 | High Versus Low Positive End-Expiratory Pressure in Mechanically Ventilated Patients with Acute Heart Failure | Min-Seok Kim (Ulsan Univ., Korea) | ||
| 09:50-10:00 | Relationship between Left Ventricular Reverse Remodeling and Guideline-Directed Medical Therapy Intensity Score in De Novo Heart Failure with Reduced Ejection Fraction Patients: Insight from TRANS-HF trial | Taeil Yang (Gachon Univ., Korea) | ||
| 10:00-10:10 | Real-world Eligibility of Finerenone in Patients with Heart Failure: Insights from the Korean Heart Failure III (KorHF III) Registry | Moojun Kim (Yonsei Univ., Korea) | ||
| 10:10-10:20 | Impact of Cardiac Contractility Modulation on Reverse Remodeling and Clinical Outcomes in Heart Failure: A Systematic Review and Meta-analysis | David Yobel (Ngoerah Hospital, Indonesia) | ||
Young Investigator Award Session
| Room C | ||||
| 10:40-12:01 | ENG Young Investigator Award Session |
Mi-Seung Shin (Gachon Univ., Korea)
, Seonghoon Choi (Hallym Univ., Korea) |
||
| Judges: Jang-Won Son (Yeungnam Univ., Korea), Minjae Yoon (Seoul National Univ., Korea), Mi-Hyang Jung (The Catholic Univ., Korea), Uram Jin (Ajou Univ., Korea) | ||||
| 10:40-10:49 | Modification of Stress Echocardiography Criteria in HFA-PEFF Algorithm: Based on the Hemodynamic Study | Ji Hyun Cha (Sungkyunkwan Univ., Korea) | ||
| 10:49-10:58 | Respiratory Sarcopenia as a Novel and Powerful Predictor of Mortality in Older Patients Hospitalized for Heart Failure: Findings from the SONIC-HF Study | Taisuke Nakade (Juntendo Univ., Japan) | ||
| 10:58-11:07 | Development of Multimodal Digital Stethoscope System for Self-monitoring of Heart Failure Status | Qun Wei (Keimyung Univ., Korea) | ||
| 11:07-11:16 | Transcriptomic and Network-based Profiling Reveals Key Molecular Pathways and Therapeutic Targets in Dilated Cardiomyopathy | Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia) | ||
| 11:16-11:25 | Imagenetics in Non-ischemic Dilated Cardiomyopathy : Linking Cardiac Magnetic Resonance Imaging Phenotypes to Genotypic Signatures | Jooyeon Lee (Yonsei Univ., Korea) | ||
| 11:25-11:34 | Eligibility for FINEARTS-HF in a Real-world Nationwide Cohort with Heart Failure with Mildly Reduced or Preserved Ejection Fraction | Benedikt Beer (Karolinska Institutet, Sweden) | ||
| 11:34-11:43 | Impact of a Discharge Checklist on Guideline-directed Medical Therapy Adherence and Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: A Comparative Observational Study | Eunjoung Choi (Korea Univ., Korea) | ||
| 11:43-11:52 | Modeling HeartBrain Crosstalk in Heart Failure under SGLT2 Inhibition: A Digital Twin Simulation Using Transcriptomics and LigandReceptor Networks | Javad Alizargar (National Taipei Univ., Taiwan) | ||
| 11:52-12:01 | Distinct Inflammasome and Type I Interferon Pathways Drive Divergent Immune Dynamics in Vaccine-associated and Conventional Myocarditis | Yongjae Lee (KAIST, Korea) | ||
Luncheon Session 6 
| Room C | ||||
| 12:05-13:00 |
KOR
Luncheon Session 6
|
Il Suk Sohn (Kyung Hee Univ., Korea)
, Hae-Young Lee (Seoul National Univ., Korea) |
||
| 12:05-12:30 | CV Benefits of Dapagliflozin in Heart Failure | Ju-Hee Lee (Chungbuk National Univ., Korea) | ||
| 12:30-13:00 | Hypertension Management with Valsartan & Amlodipine | Min-Seok Kim (Ulsan Univ., Korea) | ||
[Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science
|
Room C Learning Objective + Session Rationale + |
||||
| 13:00-14:20 | KOR [Joint Session with NIH] Collaborative Research for Advancing Heart Failure Science |
Byung Su Yoo (Yonsei Wonju Univ., Korea)
, Won-Ho Kim (Korea National Institute of Health, Korea) |
||
| 심부전 연구자들이 국가적 연구 자원과 데이터베이스를 이해하고, 인공지능·디지털 헬스·유전체 분석 등 최신 융합기술을 활용한 공동 연구 전략을 수립할 수 있도록 한다. | ||||
| 심부전 연구를 위한 많은 연구 자원과 데이터베이스가 있다는 것은 알고 있지만 구체적으로 어떤 것들이 있고 어떻게 활용할 수 있는지 모르는 경우가 많다. 따라서 막연하게만 알고 있는 연구 자원에 대해서 알아보고 이것을 어떻게 얻고 분석할 수 있을지에 대하여 기초부터 차근차근 알아보는 시간이다. | ||||
| 13:00-13:10 | 어렵지 않아요: 자원 신청부터 활용까지 |
|
Hyun Joung Lim (Korea National Institute of Health, Korea) | |
| 13:10-13:20 | 당신의 연구에 필요한 유전체 · 오믹스 데이터, 우리가 지원합니다 |
|
Sang Cheol Kim (Korea National Institute of Health, Korea) | |
| 13:20-13:30 | 너도 할 수 있어: 국가 자원을 활용한 실제 연구 사례 |
|
Yongho Jee (Ewha Womans Univ., Korea) | |
| 13:30-13:40 | AI와 국가 데이터의 만남: 실전 분석 사례와 가능성 |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 13:40-13:50 | Registry 통합과 미래 활용 전략, Pragmatic RCT로 나아가는 길 |
|
Jong-Chan Youn (The Catholic Univ., Korea) | |
| 13:50-14:20 | Discussion |
Bong-Jo Kim (Korea National Institute of Health, Korea) , Hyo Suk Ahn (The Catholic Univ., Korea) , Ju-Hee Lee (Chungbuk National Univ., Korea) , Jae-Pil Jeon (Korea National Institute of Health, Korea) , Junho Hyun (Ulsan Univ., Korea) |
||
Achieving Survival Benefit in Heart Failure with Beta-Blockers
| Room C | ||||
| 14:20-15:30 |
KOR
Achieving Survival Benefit in Heart Failure with Beta-Blockers |
Shung Chull Chae (Kyungpook National Univ., Korea)
, Jin-Yong Hwang (Gyeongsang National Univ., Korea) |
||
| 14:20-14:50 | The Greatest Advantage of Carvedilol and Its Clinical Utility |
|
Jung Hyun Choi (Pusan National Univ., Korea) | |
| 14:50-15:05 | Sharing Real-World Experience I |
|
Hyemoon Chung (Kyung Hee Univ., Korea) | |
| 15:05-15:20 | Sharing Real-World Experience II |
|
Soo Yong Lee (Pusan National Univ., Korea) | |
| 15:20-15:30 | Discussion | Jihun Jang (Inha Univ., Korea) | ||
[Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better?
|
Room C Learning Objective + Session Rationale + |
||||
| 15:40-17:00 | KOR [Advanced Heart Failure Research Working Group] Advancing Heart Transplantation: Can We Do Better? |
Seok Min Kang (Yonsei Univ., Korea)
, Jin-Oh Choi (Sungkyunkwan Univ., Korea) |
||
| 심장이식 환자에서 급·아급성 거부반응, 신장기능 악화, 혈관병증(CAV) 등 주요 이식 후 합병증의 조기 진단과 예방 전략을 이해하고, 실제 임상에 적용할 수 있도록 한다. | ||||
| 심장이식 후 생존율 향상과 삶의 질 개선을 위해, 주요 합병증을 예방하기 위한 최신 진단 기법과 예방 전략을 고찰해보고자 한다. | ||||
| 15:40-15:55 | How to Prevent Acute/Subacute Rejection |
|
Darae Kim (Sungkyunkwan Univ., Korea) | |
| 15:55-16:10 | How to Prevent Biopsy Negative Graft Dysfunction |
|
Sang Eun Lee (Ulsan Univ., Korea) | |
| 16:10-16:25 | How to Prevent Worsening Renal Function |
|
Jae Yeong Cho (Chonnam National Univ., Korea) | |
| 16:25-16:40 | How to Prevent Coronary Allograft Vasculopathy |
|
In-Cheol Kim (Keimyung Univ., Korea) | |
| 16:40-17:00 | Discussion |
Jaewon Oh (Yonsei Univ., Korea) , Jong-Chan Youn (The Catholic Univ., Korea) , Hyun-Jai Cho (Seoul National Univ., Korea) , Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea) |
||
- The Korean Society of Heart Failure
- TEL: +82-2-3275-5335 | FAX: +82-2-3275-5336 | E-Mail: kshf3@kshf.or.kr
- Business Registration No. : 234-82- 63394 | Name of Representative : ByungSu Yoo
